Biological Information

Background Information:

Eph family tyrosine kinase receptors consist of two groups: EphA group members respond to ephrin-A, which is anchored to the cell membrane by glycosylphosphatidylinositol, whereas EphB group members respond to ephrin-B, containing a transmembrane domain. Among them, only EphA4 can cross-respond to both ephrin-A and -B. Expression of the EPB4 (EphB4, Ephrin type-B receptor 4, Tyrosine-protein kinase receptor HTK, EC 2.7.1.112) receptors and their ephrinB ligands play a key role in normal vascular formation as well as in diabetic retinopathy, malignant tumor progression and angiogenesis. Inhibition of EPB4 may be used in the treatment of diabetic renopathy and angioproliferative tumors. GenBank AY056047

Target Class:

Kinase

Family:

RTK

Sub Family:

Protein Tyrosine

Protein Name:

EphB4

Protein Aliases:

Hepatoma transmembrane kinase|Tyrosine-protein kinase TYRO11

Accession Number:

NM_004444.4

UniProt Number:

P54760

Gene Name:

EPHB4

Gene ID:

2050

Gene Aliases:

Tyro11

Target Species:

Human

Usage

Product Type:

Enzymes

Application:

Drug Discovery & Development

Storage Conditions:

6 months at -70°C

Usage disclaimer:

These products may be covered by issued US and/or foreign patents, patent applications and subject to a Limited Use Label License. Please visit discoverx.com/license for a list of products that are governed by limited use label license terms and relevant patent and trademark information.

Assay Information

Assay Type:

Enzymatic

Clinical Relevance

Therapeutic Area:

Oncology/Immuno-Oncology